rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2002-12-12
|
pubmed:abstractText |
The rationale for using tazarotene in oral lichen planus (OLP) is its regulatory action on the growth and differentiation of keratinocytes and on inflammation. This randomized, placebo-controlled study addresses evaluation of the effects of topic tazarotene in the treatment of OLP.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
D
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1354-523X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
8
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
291-5
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12477060-Administration, Topical,
pubmed-meshheading:12477060-Aged,
pubmed-meshheading:12477060-Cell Differentiation,
pubmed-meshheading:12477060-Cell Division,
pubmed-meshheading:12477060-Female,
pubmed-meshheading:12477060-Gels,
pubmed-meshheading:12477060-Humans,
pubmed-meshheading:12477060-Keratinocytes,
pubmed-meshheading:12477060-Keratolytic Agents,
pubmed-meshheading:12477060-Lichen Planus, Oral,
pubmed-meshheading:12477060-Male,
pubmed-meshheading:12477060-Matched-Pair Analysis,
pubmed-meshheading:12477060-Middle Aged,
pubmed-meshheading:12477060-Nicotinic Acids,
pubmed-meshheading:12477060-Placebos,
pubmed-meshheading:12477060-Remission Induction,
pubmed-meshheading:12477060-Retinoids,
pubmed-meshheading:12477060-Sensation Disorders,
pubmed-meshheading:12477060-Single-Blind Method,
pubmed-meshheading:12477060-Statistics, Nonparametric,
pubmed-meshheading:12477060-Taste Disorders,
pubmed-meshheading:12477060-Treatment Outcome
|
pubmed:year |
2002
|
pubmed:articleTitle |
Oral lichen planus: a preliminary clinical study on treatment with tazarotene.
|
pubmed:affiliation |
Department of Odontostomatology and Surgery, University of Bari, Bari, Italy. petruzmf@tin.it
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|